Adocia ADR (Sponsored)

(ADOCY)

By |

Profile

Adocia is a clinical stage biotechnology company. It specializes in the development of formulations of already approved therapeutic proteins. The firm has developed Biochaperone proprietary technological platform to enhance the effectiveness of therapeutic proteins. The company's product pipeline includes biochaprone lispro, biochaparone combo, biochaparone human glucagon etc. Its patent portfolio mainly consists of chronic wound healing, insulin therapy, and monoclonal antibodies.

Contact Information

Website: www.adocia.com
Main Phone: +33 472610610
Address: 115 avenue Lacassagne
City / Town: Lyon
Country: FRA
Postal Code: 69003

Issuer Information

Exchange: OTO
Employees: 129
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 19.70 $ 0. (0.00%)
Last Price 19.70 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 19.70
Last Trade Volume 0 52 Wk Hi 21.28 52 Wk Low 17.00
Market Cap 136.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 6,909,328.00 EPS (TTM) -1.44 PE Ratio N/A Exchange OTCPK
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1